STAT+: Europe proposes shortening drug exclusivity period

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. I hope my fellow Midwesterners stay warm this weekend. Let’s get into the news today.

A new FDA drug regulator will face a distrustful staff

On Monday, Tracy Beth Høeg will become acting director of the FDA’s drug center.

Continue to STAT+ to read the full story…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *